Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars - CNBC
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars CNBCLilly forecasts 2025 profit largely above estimates on weight-loss drug strength Yahoo FinanceLilly reports full Q4 2024 financial results and provides 2025 guidance Investors | Eli Lilly and CompanyEli Lilly’s Full-Year Profit Views in Line After Recent Misses Bloomberg
- Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars CNBC
- Lilly forecasts 2025 profit largely above estimates on weight-loss drug strength Yahoo Finance
- Lilly reports full Q4 2024 financial results and provides 2025 guidance Investors | Eli Lilly and Company
- Eli Lilly’s Full-Year Profit Views in Line After Recent Misses Bloomberg